MCKESSON CORP (MCK)
US58155Q1031 - Common Stock
These S&P500 stocks are moving in today's session
Top S&P500 movers in Friday's session
McKesson Corporation Declares Quarterly Dividend
MCK December 20th Options Begin Trading
McKesson Takes Over #152 Spot From Republic Services
Buying Power of BNB vs. McKesson at New 52-Week High
Notable Tuesday Option Activity: MCK, GNRC, ELF
Tuesday Sector Laggards: Healthcare, Financial
S&P 500 Movers: MCK, FCX
McKesson Corporation Announces Second Quarter Fiscal 2025 Earnings Release Date
Oversold Conditions For McKesson (MCK)
Interest Rates, Private Equity, Stocks, Football...We've Got It All
Including an interview with former NFL linebacker Brandon Copeland.
Thursday Sector Laggards: Industrial, Healthcare
Noteworthy Thursday Option Activity: MCK, WYNN, GOOGL
MCK Crosses Below Key Moving Average Level
McKesson Corporation Announces Sale of Rexall and Well.ca Businesses to Birch Hill Equity Partners
Drug distributors strike $300 million opioid settlement with US health plans
(Reuters) -The three largest U.S. drug distributors have agreed to pay $300 million to resolve claims by health insurers and benefit plans that they helped fuel the deadly U.S. opioid epidemic, according to court papers filed on Friday. The proposed class action settlement with McKesson Corp, Cencora Inc and Cardinal Health Inc was disclosed in a filing in federal court in Cleveland, Ohio, and requires a judge's approval. Paul Geller, a lawyer for the plaintiffs, said in a statement that Friday's deal covered third-party payers like union funds that "largely paid for the overprescribed and overmarketed pills and for the treatment required when their plan beneficiaries inevitably suffered opioid use disorder."
McKesson to Buy Stake in Florida Cancer Chain for $2.49 Billion
McKesson Corp. agreed to buy a controlling stake in an arm of Florida Cancer Specialists & Research Institute, a privately held operator of clinics.
McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute’s Core Ventures
Friday Sector Laggards: Utilities, Healthcare
McKesson In Talks for Stake in Florida Cancer Specialists
McKesson Corp. is in advanced talks to buy a controlling stake in Florida Cancer Specialists & Research Institute, a privately-held operator of oncology clinics, according to people familiar with the matter.
See How McKesson Ranks Among Analysts' Top Picks With Strong Buyback Activity
See Which Of The Latest 13F Filers Holds McKesson
Cardinal Health Poised To Retake Key Level On Bullish Fiscal 2025 View
Cardinal Health reported better-than-expected fiscal fourth-quarter earnings and hiked 2025 profit expectations
3 Healthcare Stocks to Sell in August Before They Crash & Burn
Investors are looking to the healthcare sector for safe harbor. But these are three healthcare stocks to sell in August 2024.